Mach7 Technologies Ltd
ASX:M7T
Mach7 Technologies Ltd
Cash Equivalents
Mach7 Technologies Ltd
Cash Equivalents Peer Comparison
Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
Company | Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Mach7 Technologies Ltd
ASX:M7T
|
Cash Equivalents
AU$22.7m
|
CAGR 3-Years
40%
|
CAGR 5-Years
51%
|
CAGR 10-Years
61%
|
|
4DMedical Ltd
ASX:4DX
|
Cash Equivalents
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
CogState Ltd
ASX:CGS
|
Cash Equivalents
$25.3m
|
CAGR 3-Years
6%
|
CAGR 5-Years
44%
|
CAGR 10-Years
12%
|
|
Pro Medicus Ltd
ASX:PME
|
Cash Equivalents
AU$99.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Medibio Ltd
ASX:MEB
|
Cash Equivalents
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Medadvisor Ltd
ASX:MDR
|
Cash Equivalents
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Mach7 Technologies Ltd's Cash Equivalents?
Cash Equivalents
22.7m
AUD
Based on the financial report for Dec 31, 2023, Mach7 Technologies Ltd's Cash Equivalents amounts to 22.7m AUD.
What is Mach7 Technologies Ltd's Cash Equivalents growth rate?
Cash Equivalents CAGR 10Y
61%
Over the last year, the Cash Equivalents growth was 10%. The average annual Cash Equivalents growth rates for Mach7 Technologies Ltd have been 40% over the past three years , 51% over the past five years , and 61% over the past ten years .